Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?
Psoriasis is a chronic, immune mediated, systemic inflammatory skin disease with a reported prevalence of 0.6%–4.8% in the general population. Bipolar disorder (BP) is a severe episodic psychiatric disorder that ranks as the fourth leading cause of disability. Recent evidence suggests that genetic a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-06-01
|
| Series: | General Psychiatry |
| Online Access: | https://gpsych.bmj.com/content/33/3/e100181.full |